Actinium Pharmaceuticals, Inc. (ATNM)

Actinium Pharmaceuticals Revenue

Actinium Pharmaceuticals had revenue of $81.00K in the twelve months ending March 31, 2024, down -10.00% year-over-year. In the year 2023, Actinium Pharmaceuticals had annual revenue of $81.00K, a decrease of -92.14%.

• Revenue (ttm): $81.00K
• Revenue Growth: -10.00%
• P/S Ratio: 2,493.25
• Revenue / Employee: $1,653
• Employees: 49
• Market Cap: 201.95M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	81.00K	-949.00K	-92.14%
Dec 31, 2022	1.03M	-114.00K	-9.97%
Dec 31, 2021	1.14M	-	-
Dec 31, 2020	0	-	-
Dec 31, 2019	0	-	-
Dec 31, 2018	0	-	-
Dec 31, 2017	0	-	-
Dec 31, 2016	0	-	-
Dec 31, 2015	0	-	-
Dec 31, 2014	0	-	-
Dec 31, 2013	0	-	-
Dec 31, 2012	0	-	-
Dec 31, 2011	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.